Key result
A modified ecarin clotting time assay with excess prothrombin and fibrinogen prevents falsely elevated recombinant hirudin levels in patients undergoing cardiopulmonary bypass.
Why the study?
Does a modified ECT assay with excess prothrombin and fibrinogen improve the accuracy of r-hirudin monitoring in patients undergoing cardiovascular surgery?
Does a modified ECT assay with excess prothrombin and fibrinogen improve the accuracy of r-hirudin monitoring in patients undergoing cardiovascular surgery?
A modified ECT assay with excess prothrombin and fibrinogen prevents falsely elevated r-hirudin levels during cardiopulmonary bypass.
Answers are grounded in this paper and cite their sources.
May improve r-hirudin monitoring accuracy during CPB; leaves open prospective validation before clinical adoption.
Recombinant hirudin (r-hirudin) is being used increasingly for therapeutic anticoagulation in patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery. Although multiple laboratory methods are available for measuring r-hirudin, the ecarin clotting time (ECT) is the most commonly used for this purpose. Ecarin (extracted from snake venom) converts prothrombin to meizothrombin, which promotes clot formation. Direct thrombin inhibitors, like r-hirudin, bind meizothrombin and yield a linear, dose-dependent prolongation of ECT. Low levels of prothrombin and fibrinogen in plasma samples can lead to higher ECT; suggesting falsely elevated r-hirudin levels. A modified ECT assay with prothrombin and fibrinogen in excess was optimized using an orthogonal array method to eliminate the variations in patients' plasma prothrombin and/or fibrinogen levels for accurate determinations of plasma r-hirudin levels. By using the modified ECT assay, falsely elevated r-hirudin levels can be avoided in patients undergoing cardiopulmonary bypass, thus providing reliable and accurate r-hirudin monitoring in this clinical setting.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2006) studied Heparin-induced thrombocytopenia undergoing cardiovascular surgery. Modified ecarin clotting time (ECT) assay was evaluated on Accurate determination of plasma r-hirudin levels. A modified ecarin clotting time assay with excess prothrombin and fibrinogen prevents falsely elevated recombinant hirudin levels in patients undergoing cardiopulmonary bypass.
Synapse has enriched 10 related papers. Consider them for comparative context: